Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $42.43M | $110.74M | 22.49% | +$68.31M |
| Beam Therapeutics Inc.(BEAM) | 4,540,132 | 4,540,132 | 0 | $77.23M | $110.19M | 22.38% | +$32.96M |
| Maze Therapeutics, Inc.(MAZE) | 4,120,053 | 4,120,053 | 0 | $50.59M | $106.83M | 21.70% | +$56.24M |
| Vir Biotechnology, Inc.(VIR) | 12,916,663 | 12,916,663 | 0 | $65.10M | $73.75M | 14.98% | +$8.65M |
| Lyell Immunopharma, Inc.(LYEL) | 1,820,634 | 2,759,072 | +938,438 | $16.11M | $44.81M | 9.10% | +$28.69M |
| Erasca, Inc.(ERAS) | 11,055,554 | 11,055,554 | 0 | $14.10M | $24.10M | 4.89% | +$10.01M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $9.91M | $21.19M | 4.30% | +$11.28M |
| Q32 Bio Inc.(QTTB) | 320,482 | 320,482 | 0 | $477.5K | $634.6K | 0.13% | +$157.0K |
| Cero Therapeutics Holdings Inc. | 22,389 | 22,389 | 0 | $215.6K | $114.0K | 0.02% | -$101.6K |
| Unity Biotechnology Inc. | 1,004,817 | 0 | -1,004,817 | $385.9K | $0 | — | -$385.9K |
| Verve Therapeutics Inc. | 2,008,809 | 0 | -2,008,809 | $22.56M | $0 | — | -$22.56M |